Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study

Table 1

Baseline characteristics of patients.

Female (, %)	37 (72.6)
Age (years)
Mean arterial blood pressure (mmHg)
Heart rate (/min)
Comorbid diseases (, %)
(i) Hypertension	48 (94.1)
(ii) Cardiovascular diseases	11(21.5)
Dialysis vintage (years)
BUN (mg/dL)
Serum creatinine (mg/dL)
Serum albumin (g/dL)
LDL-cholesterol (mg/dL)
Single-pool
Plasma glucose (mg/dL)
Hemoglobin A1C (%)
Plasma sodium (mEq/L)
Plasma potassium (mEq/L)
Plasma chloride (mEq/L)
Plasma bicarbonate (mEq/L)
Insulin types
(i) Humulin premix	43 (84.3)
(ii) Humulin N	8 (15.7)
Antihypertensive agents (, %)
(i) Calcium channel blockers	22 (43.1)
(ii) Beta blockers	18 (35.3)
(iii) Diuretics	19 (37.3)
(iv) Alpha blockers	6 (11.8)
(v) Renin angiotensin aldosterone blockers	9 (17.7)
(vi) Others	26 (50.9)

Data is presented as mean with SD and percentage.